Global CD19 Target Drug Supply, Demand and Key Producers, 2023-2029
The global CD19 Target Drug market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
CD19-target drugs are a class of drugs used to treat specific types of B cell-related diseases. These drugs interfere with the function of the immune system by targeting the CD19 antigen on the surface of B cells. CD19 (Cluster of Differentiation 19) is a cell surface antigen that is usually expressed on the surface of B lymphocytes, but not on T cells, NK cells or other immune cells. Drugs targeting the CD19 antigen are used to treat B-cell lymphoma and other B-cell-related diseases.
This report studies the global CD19 Target Drug production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for CD19 Target Drug, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of CD19 Target Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global CD19 Target Drug total production and demand, 2018-2029, (K Units)
Global CD19 Target Drug total production value, 2018-2029, (USD Million)
Global CD19 Target Drug production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global CD19 Target Drug consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: CD19 Target Drug domestic production, consumption, key domestic manufacturers and share
Global CD19 Target Drug production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global CD19 Target Drug production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global CD19 Target Drug production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global CD19 Target Drug market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ADC Therapeutics SA, Bristol Myers Squibb, Kite Pharma, Inc., Viela Bio, Novartis Pharma AG, Amgen, Inc., Juventas, FOSUN PHARMA and JW Therapeutics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World CD19 Target Drug market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global CD19 Target Drug Market, By Region:
1. How big is the global CD19 Target Drug market?
2. What is the demand of the global CD19 Target Drug market?
3. What is the year over year growth of the global CD19 Target Drug market?
4. What is the production and production value of the global CD19 Target Drug market?
5. Who are the key producers in the global CD19 Target Drug market?
CD19-target drugs are a class of drugs used to treat specific types of B cell-related diseases. These drugs interfere with the function of the immune system by targeting the CD19 antigen on the surface of B cells. CD19 (Cluster of Differentiation 19) is a cell surface antigen that is usually expressed on the surface of B lymphocytes, but not on T cells, NK cells or other immune cells. Drugs targeting the CD19 antigen are used to treat B-cell lymphoma and other B-cell-related diseases.
This report studies the global CD19 Target Drug production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for CD19 Target Drug, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of CD19 Target Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global CD19 Target Drug total production and demand, 2018-2029, (K Units)
Global CD19 Target Drug total production value, 2018-2029, (USD Million)
Global CD19 Target Drug production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global CD19 Target Drug consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: CD19 Target Drug domestic production, consumption, key domestic manufacturers and share
Global CD19 Target Drug production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global CD19 Target Drug production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global CD19 Target Drug production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global CD19 Target Drug market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ADC Therapeutics SA, Bristol Myers Squibb, Kite Pharma, Inc., Viela Bio, Novartis Pharma AG, Amgen, Inc., Juventas, FOSUN PHARMA and JW Therapeutics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World CD19 Target Drug market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global CD19 Target Drug Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- CD19 Target
- CD19+CD3 Target
- CD19+DNA Target
- Lymphoma
- Acute Lymphoblastic Leukemia
- Other
- ADC Therapeutics SA
- Bristol Myers Squibb
- Kite Pharma, Inc.
- Viela Bio
- Novartis Pharma AG
- Amgen, Inc.
- Juventas
- FOSUN PHARMA
- JW Therapeutics
1. How big is the global CD19 Target Drug market?
2. What is the demand of the global CD19 Target Drug market?
3. What is the year over year growth of the global CD19 Target Drug market?
4. What is the production and production value of the global CD19 Target Drug market?
5. Who are the key producers in the global CD19 Target Drug market?
1 SUPPLY SUMMARY
1.1 CD19 Target Drug Introduction
1.2 World CD19 Target Drug Supply & Forecast
1.2.1 World CD19 Target Drug Production Value (2018 & 2022 & 2029)
1.2.2 World CD19 Target Drug Production (2018-2029)
1.2.3 World CD19 Target Drug Pricing Trends (2018-2029)
1.3 World CD19 Target Drug Production by Region (Based on Production Site)
1.3.1 World CD19 Target Drug Production Value by Region (2018-2029)
1.3.2 World CD19 Target Drug Production by Region (2018-2029)
1.3.3 World CD19 Target Drug Average Price by Region (2018-2029)
1.3.4 North America CD19 Target Drug Production (2018-2029)
1.3.5 Europe CD19 Target Drug Production (2018-2029)
1.3.6 China CD19 Target Drug Production (2018-2029)
1.3.7 Japan CD19 Target Drug Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 CD19 Target Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 CD19 Target Drug Major Market Trends
2 DEMAND SUMMARY
2.1 World CD19 Target Drug Demand (2018-2029)
2.2 World CD19 Target Drug Consumption by Region
2.2.1 World CD19 Target Drug Consumption by Region (2018-2023)
2.2.2 World CD19 Target Drug Consumption Forecast by Region (2024-2029)
2.3 United States CD19 Target Drug Consumption (2018-2029)
2.4 China CD19 Target Drug Consumption (2018-2029)
2.5 Europe CD19 Target Drug Consumption (2018-2029)
2.6 Japan CD19 Target Drug Consumption (2018-2029)
2.7 South Korea CD19 Target Drug Consumption (2018-2029)
2.8 ASEAN CD19 Target Drug Consumption (2018-2029)
2.9 India CD19 Target Drug Consumption (2018-2029)
3 WORLD CD19 TARGET DRUG MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World CD19 Target Drug Production Value by Manufacturer (2018-2023)
3.2 World CD19 Target Drug Production by Manufacturer (2018-2023)
3.3 World CD19 Target Drug Average Price by Manufacturer (2018-2023)
3.4 CD19 Target Drug Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global CD19 Target Drug Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for CD19 Target Drug in 2022
3.5.3 Global Concentration Ratios (CR8) for CD19 Target Drug in 2022
3.6 CD19 Target Drug Market: Overall Company Footprint Analysis
3.6.1 CD19 Target Drug Market: Region Footprint
3.6.2 CD19 Target Drug Market: Company Product Type Footprint
3.6.3 CD19 Target Drug Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: CD19 Target Drug Production Value Comparison
4.1.1 United States VS China: CD19 Target Drug Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: CD19 Target Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: CD19 Target Drug Production Comparison
4.2.1 United States VS China: CD19 Target Drug Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: CD19 Target Drug Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: CD19 Target Drug Consumption Comparison
4.3.1 United States VS China: CD19 Target Drug Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: CD19 Target Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based CD19 Target Drug Manufacturers and Market Share, 2018-2023
4.4.1 United States Based CD19 Target Drug Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers CD19 Target Drug Production Value (2018-2023)
4.4.3 United States Based Manufacturers CD19 Target Drug Production (2018-2023)
4.5 China Based CD19 Target Drug Manufacturers and Market Share
4.5.1 China Based CD19 Target Drug Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers CD19 Target Drug Production Value (2018-2023)
4.5.3 China Based Manufacturers CD19 Target Drug Production (2018-2023)
4.6 Rest of World Based CD19 Target Drug Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based CD19 Target Drug Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers CD19 Target Drug Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers CD19 Target Drug Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World CD19 Target Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 CD19 Target
5.2.2 CD19+CD3 Target
5.2.3 CD19+DNA Target
5.3 Market Segment by Type
5.3.1 World CD19 Target Drug Production by Type (2018-2029)
5.3.2 World CD19 Target Drug Production Value by Type (2018-2029)
5.3.3 World CD19 Target Drug Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World CD19 Target Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Lymphoma
6.2.2 Acute Lymphoblastic Leukemia
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World CD19 Target Drug Production by Application (2018-2029)
6.3.2 World CD19 Target Drug Production Value by Application (2018-2029)
6.3.3 World CD19 Target Drug Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 ADC Therapeutics SA
7.1.1 ADC Therapeutics SA Details
7.1.2 ADC Therapeutics SA Major Business
7.1.3 ADC Therapeutics SA CD19 Target Drug Product and Services
7.1.4 ADC Therapeutics SA CD19 Target Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 ADC Therapeutics SA Recent Developments/Updates
7.1.6 ADC Therapeutics SA Competitive Strengths & Weaknesses
7.2 Bristol Myers Squibb
7.2.1 Bristol Myers Squibb Details
7.2.2 Bristol Myers Squibb Major Business
7.2.3 Bristol Myers Squibb CD19 Target Drug Product and Services
7.2.4 Bristol Myers Squibb CD19 Target Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Bristol Myers Squibb Recent Developments/Updates
7.2.6 Bristol Myers Squibb Competitive Strengths & Weaknesses
7.3 Kite Pharma, Inc.
7.3.1 Kite Pharma, Inc. Details
7.3.2 Kite Pharma, Inc. Major Business
7.3.3 Kite Pharma, Inc. CD19 Target Drug Product and Services
7.3.4 Kite Pharma, Inc. CD19 Target Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Kite Pharma, Inc. Recent Developments/Updates
7.3.6 Kite Pharma, Inc. Competitive Strengths & Weaknesses
7.4 Viela Bio
7.4.1 Viela Bio Details
7.4.2 Viela Bio Major Business
7.4.3 Viela Bio CD19 Target Drug Product and Services
7.4.4 Viela Bio CD19 Target Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Viela Bio Recent Developments/Updates
7.4.6 Viela Bio Competitive Strengths & Weaknesses
7.5 Novartis Pharma AG
7.5.1 Novartis Pharma AG Details
7.5.2 Novartis Pharma AG Major Business
7.5.3 Novartis Pharma AG CD19 Target Drug Product and Services
7.5.4 Novartis Pharma AG CD19 Target Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Novartis Pharma AG Recent Developments/Updates
7.5.6 Novartis Pharma AG Competitive Strengths & Weaknesses
7.6 Amgen, Inc.
7.6.1 Amgen, Inc. Details
7.6.2 Amgen, Inc. Major Business
7.6.3 Amgen, Inc. CD19 Target Drug Product and Services
7.6.4 Amgen, Inc. CD19 Target Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Amgen, Inc. Recent Developments/Updates
7.6.6 Amgen, Inc. Competitive Strengths & Weaknesses
7.7 Juventas
7.7.1 Juventas Details
7.7.2 Juventas Major Business
7.7.3 Juventas CD19 Target Drug Product and Services
7.7.4 Juventas CD19 Target Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Juventas Recent Developments/Updates
7.7.6 Juventas Competitive Strengths & Weaknesses
7.8 FOSUN PHARMA
7.8.1 FOSUN PHARMA Details
7.8.2 FOSUN PHARMA Major Business
7.8.3 FOSUN PHARMA CD19 Target Drug Product and Services
7.8.4 FOSUN PHARMA CD19 Target Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 FOSUN PHARMA Recent Developments/Updates
7.8.6 FOSUN PHARMA Competitive Strengths & Weaknesses
7.9 JW Therapeutics
7.9.1 JW Therapeutics Details
7.9.2 JW Therapeutics Major Business
7.9.3 JW Therapeutics CD19 Target Drug Product and Services
7.9.4 JW Therapeutics CD19 Target Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 JW Therapeutics Recent Developments/Updates
7.9.6 JW Therapeutics Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 CD19 Target Drug Industry Chain
8.2 CD19 Target Drug Upstream Analysis
8.2.1 CD19 Target Drug Core Raw Materials
8.2.2 Main Manufacturers of CD19 Target Drug Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 CD19 Target Drug Production Mode
8.6 CD19 Target Drug Procurement Model
8.7 CD19 Target Drug Industry Sales Model and Sales Channels
8.7.1 CD19 Target Drug Sales Model
8.7.2 CD19 Target Drug Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 CD19 Target Drug Introduction
1.2 World CD19 Target Drug Supply & Forecast
1.2.1 World CD19 Target Drug Production Value (2018 & 2022 & 2029)
1.2.2 World CD19 Target Drug Production (2018-2029)
1.2.3 World CD19 Target Drug Pricing Trends (2018-2029)
1.3 World CD19 Target Drug Production by Region (Based on Production Site)
1.3.1 World CD19 Target Drug Production Value by Region (2018-2029)
1.3.2 World CD19 Target Drug Production by Region (2018-2029)
1.3.3 World CD19 Target Drug Average Price by Region (2018-2029)
1.3.4 North America CD19 Target Drug Production (2018-2029)
1.3.5 Europe CD19 Target Drug Production (2018-2029)
1.3.6 China CD19 Target Drug Production (2018-2029)
1.3.7 Japan CD19 Target Drug Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 CD19 Target Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 CD19 Target Drug Major Market Trends
2 DEMAND SUMMARY
2.1 World CD19 Target Drug Demand (2018-2029)
2.2 World CD19 Target Drug Consumption by Region
2.2.1 World CD19 Target Drug Consumption by Region (2018-2023)
2.2.2 World CD19 Target Drug Consumption Forecast by Region (2024-2029)
2.3 United States CD19 Target Drug Consumption (2018-2029)
2.4 China CD19 Target Drug Consumption (2018-2029)
2.5 Europe CD19 Target Drug Consumption (2018-2029)
2.6 Japan CD19 Target Drug Consumption (2018-2029)
2.7 South Korea CD19 Target Drug Consumption (2018-2029)
2.8 ASEAN CD19 Target Drug Consumption (2018-2029)
2.9 India CD19 Target Drug Consumption (2018-2029)
3 WORLD CD19 TARGET DRUG MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World CD19 Target Drug Production Value by Manufacturer (2018-2023)
3.2 World CD19 Target Drug Production by Manufacturer (2018-2023)
3.3 World CD19 Target Drug Average Price by Manufacturer (2018-2023)
3.4 CD19 Target Drug Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global CD19 Target Drug Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for CD19 Target Drug in 2022
3.5.3 Global Concentration Ratios (CR8) for CD19 Target Drug in 2022
3.6 CD19 Target Drug Market: Overall Company Footprint Analysis
3.6.1 CD19 Target Drug Market: Region Footprint
3.6.2 CD19 Target Drug Market: Company Product Type Footprint
3.6.3 CD19 Target Drug Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: CD19 Target Drug Production Value Comparison
4.1.1 United States VS China: CD19 Target Drug Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: CD19 Target Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: CD19 Target Drug Production Comparison
4.2.1 United States VS China: CD19 Target Drug Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: CD19 Target Drug Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: CD19 Target Drug Consumption Comparison
4.3.1 United States VS China: CD19 Target Drug Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: CD19 Target Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based CD19 Target Drug Manufacturers and Market Share, 2018-2023
4.4.1 United States Based CD19 Target Drug Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers CD19 Target Drug Production Value (2018-2023)
4.4.3 United States Based Manufacturers CD19 Target Drug Production (2018-2023)
4.5 China Based CD19 Target Drug Manufacturers and Market Share
4.5.1 China Based CD19 Target Drug Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers CD19 Target Drug Production Value (2018-2023)
4.5.3 China Based Manufacturers CD19 Target Drug Production (2018-2023)
4.6 Rest of World Based CD19 Target Drug Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based CD19 Target Drug Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers CD19 Target Drug Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers CD19 Target Drug Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World CD19 Target Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 CD19 Target
5.2.2 CD19+CD3 Target
5.2.3 CD19+DNA Target
5.3 Market Segment by Type
5.3.1 World CD19 Target Drug Production by Type (2018-2029)
5.3.2 World CD19 Target Drug Production Value by Type (2018-2029)
5.3.3 World CD19 Target Drug Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World CD19 Target Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Lymphoma
6.2.2 Acute Lymphoblastic Leukemia
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World CD19 Target Drug Production by Application (2018-2029)
6.3.2 World CD19 Target Drug Production Value by Application (2018-2029)
6.3.3 World CD19 Target Drug Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 ADC Therapeutics SA
7.1.1 ADC Therapeutics SA Details
7.1.2 ADC Therapeutics SA Major Business
7.1.3 ADC Therapeutics SA CD19 Target Drug Product and Services
7.1.4 ADC Therapeutics SA CD19 Target Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 ADC Therapeutics SA Recent Developments/Updates
7.1.6 ADC Therapeutics SA Competitive Strengths & Weaknesses
7.2 Bristol Myers Squibb
7.2.1 Bristol Myers Squibb Details
7.2.2 Bristol Myers Squibb Major Business
7.2.3 Bristol Myers Squibb CD19 Target Drug Product and Services
7.2.4 Bristol Myers Squibb CD19 Target Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Bristol Myers Squibb Recent Developments/Updates
7.2.6 Bristol Myers Squibb Competitive Strengths & Weaknesses
7.3 Kite Pharma, Inc.
7.3.1 Kite Pharma, Inc. Details
7.3.2 Kite Pharma, Inc. Major Business
7.3.3 Kite Pharma, Inc. CD19 Target Drug Product and Services
7.3.4 Kite Pharma, Inc. CD19 Target Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Kite Pharma, Inc. Recent Developments/Updates
7.3.6 Kite Pharma, Inc. Competitive Strengths & Weaknesses
7.4 Viela Bio
7.4.1 Viela Bio Details
7.4.2 Viela Bio Major Business
7.4.3 Viela Bio CD19 Target Drug Product and Services
7.4.4 Viela Bio CD19 Target Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Viela Bio Recent Developments/Updates
7.4.6 Viela Bio Competitive Strengths & Weaknesses
7.5 Novartis Pharma AG
7.5.1 Novartis Pharma AG Details
7.5.2 Novartis Pharma AG Major Business
7.5.3 Novartis Pharma AG CD19 Target Drug Product and Services
7.5.4 Novartis Pharma AG CD19 Target Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Novartis Pharma AG Recent Developments/Updates
7.5.6 Novartis Pharma AG Competitive Strengths & Weaknesses
7.6 Amgen, Inc.
7.6.1 Amgen, Inc. Details
7.6.2 Amgen, Inc. Major Business
7.6.3 Amgen, Inc. CD19 Target Drug Product and Services
7.6.4 Amgen, Inc. CD19 Target Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Amgen, Inc. Recent Developments/Updates
7.6.6 Amgen, Inc. Competitive Strengths & Weaknesses
7.7 Juventas
7.7.1 Juventas Details
7.7.2 Juventas Major Business
7.7.3 Juventas CD19 Target Drug Product and Services
7.7.4 Juventas CD19 Target Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Juventas Recent Developments/Updates
7.7.6 Juventas Competitive Strengths & Weaknesses
7.8 FOSUN PHARMA
7.8.1 FOSUN PHARMA Details
7.8.2 FOSUN PHARMA Major Business
7.8.3 FOSUN PHARMA CD19 Target Drug Product and Services
7.8.4 FOSUN PHARMA CD19 Target Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 FOSUN PHARMA Recent Developments/Updates
7.8.6 FOSUN PHARMA Competitive Strengths & Weaknesses
7.9 JW Therapeutics
7.9.1 JW Therapeutics Details
7.9.2 JW Therapeutics Major Business
7.9.3 JW Therapeutics CD19 Target Drug Product and Services
7.9.4 JW Therapeutics CD19 Target Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 JW Therapeutics Recent Developments/Updates
7.9.6 JW Therapeutics Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 CD19 Target Drug Industry Chain
8.2 CD19 Target Drug Upstream Analysis
8.2.1 CD19 Target Drug Core Raw Materials
8.2.2 Main Manufacturers of CD19 Target Drug Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 CD19 Target Drug Production Mode
8.6 CD19 Target Drug Procurement Model
8.7 CD19 Target Drug Industry Sales Model and Sales Channels
8.7.1 CD19 Target Drug Sales Model
8.7.2 CD19 Target Drug Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World CD19 Target Drug Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World CD19 Target Drug Production Value by Region (2018-2023) & (USD Million)
Table 3. World CD19 Target Drug Production Value by Region (2024-2029) & (USD Million)
Table 4. World CD19 Target Drug Production Value Market Share by Region (2018-2023)
Table 5. World CD19 Target Drug Production Value Market Share by Region (2024-2029)
Table 6. World CD19 Target Drug Production by Region (2018-2023) & (K Units)
Table 7. World CD19 Target Drug Production by Region (2024-2029) & (K Units)
Table 8. World CD19 Target Drug Production Market Share by Region (2018-2023)
Table 9. World CD19 Target Drug Production Market Share by Region (2024-2029)
Table 10. World CD19 Target Drug Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World CD19 Target Drug Average Price by Region (2024-2029) & (US$/Unit)
Table 12. CD19 Target Drug Major Market Trends
Table 13. World CD19 Target Drug Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World CD19 Target Drug Consumption by Region (2018-2023) & (K Units)
Table 15. World CD19 Target Drug Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World CD19 Target Drug Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key CD19 Target Drug Producers in 2022
Table 18. World CD19 Target Drug Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key CD19 Target Drug Producers in 2022
Table 20. World CD19 Target Drug Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global CD19 Target Drug Company Evaluation Quadrant
Table 22. World CD19 Target Drug Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and CD19 Target Drug Production Site of Key Manufacturer
Table 24. CD19 Target Drug Market: Company Product Type Footprint
Table 25. CD19 Target Drug Market: Company Product Application Footprint
Table 26. CD19 Target Drug Competitive Factors
Table 27. CD19 Target Drug New Entrant and Capacity Expansion Plans
Table 28. CD19 Target Drug Mergers & Acquisitions Activity
Table 29. United States VS China CD19 Target Drug Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China CD19 Target Drug Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China CD19 Target Drug Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based CD19 Target Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers CD19 Target Drug Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers CD19 Target Drug Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers CD19 Target Drug Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers CD19 Target Drug Production Market Share (2018-2023)
Table 37. China Based CD19 Target Drug Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers CD19 Target Drug Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers CD19 Target Drug Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers CD19 Target Drug Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers CD19 Target Drug Production Market Share (2018-2023)
Table 42. Rest of World Based CD19 Target Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers CD19 Target Drug Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers CD19 Target Drug Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers CD19 Target Drug Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers CD19 Target Drug Production Market Share (2018-2023)
Table 47. World CD19 Target Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World CD19 Target Drug Production by Type (2018-2023) & (K Units)
Table 49. World CD19 Target Drug Production by Type (2024-2029) & (K Units)
Table 50. World CD19 Target Drug Production Value by Type (2018-2023) & (USD Million)
Table 51. World CD19 Target Drug Production Value by Type (2024-2029) & (USD Million)
Table 52. World CD19 Target Drug Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World CD19 Target Drug Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World CD19 Target Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World CD19 Target Drug Production by Application (2018-2023) & (K Units)
Table 56. World CD19 Target Drug Production by Application (2024-2029) & (K Units)
Table 57. World CD19 Target Drug Production Value by Application (2018-2023) & (USD Million)
Table 58. World CD19 Target Drug Production Value by Application (2024-2029) & (USD Million)
Table 59. World CD19 Target Drug Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World CD19 Target Drug Average Price by Application (2024-2029) & (US$/Unit)
Table 61. ADC Therapeutics SA Basic Information, Manufacturing Base and Competitors
Table 62. ADC Therapeutics SA Major Business
Table 63. ADC Therapeutics SA CD19 Target Drug Product and Services
Table 64. ADC Therapeutics SA CD19 Target Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. ADC Therapeutics SA Recent Developments/Updates
Table 66. ADC Therapeutics SA Competitive Strengths & Weaknesses
Table 67. Bristol Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 68. Bristol Myers Squibb Major Business
Table 69. Bristol Myers Squibb CD19 Target Drug Product and Services
Table 70. Bristol Myers Squibb CD19 Target Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Bristol Myers Squibb Recent Developments/Updates
Table 72. Bristol Myers Squibb Competitive Strengths & Weaknesses
Table 73. Kite Pharma, Inc. Basic Information, Manufacturing Base and Competitors
Table 74. Kite Pharma, Inc. Major Business
Table 75. Kite Pharma, Inc. CD19 Target Drug Product and Services
Table 76. Kite Pharma, Inc. CD19 Target Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Kite Pharma, Inc. Recent Developments/Updates
Table 78. Kite Pharma, Inc. Competitive Strengths & Weaknesses
Table 79. Viela Bio Basic Information, Manufacturing Base and Competitors
Table 80. Viela Bio Major Business
Table 81. Viela Bio CD19 Target Drug Product and Services
Table 82. Viela Bio CD19 Target Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Viela Bio Recent Developments/Updates
Table 84. Viela Bio Competitive Strengths & Weaknesses
Table 85. Novartis Pharma AG Basic Information, Manufacturing Base and Competitors
Table 86. Novartis Pharma AG Major Business
Table 87. Novartis Pharma AG CD19 Target Drug Product and Services
Table 88. Novartis Pharma AG CD19 Target Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Novartis Pharma AG Recent Developments/Updates
Table 90. Novartis Pharma AG Competitive Strengths & Weaknesses
Table 91. Amgen, Inc. Basic Information, Manufacturing Base and Competitors
Table 92. Amgen, Inc. Major Business
Table 93. Amgen, Inc. CD19 Target Drug Product and Services
Table 94. Amgen, Inc. CD19 Target Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Amgen, Inc. Recent Developments/Updates
Table 96. Amgen, Inc. Competitive Strengths & Weaknesses
Table 97. Juventas Basic Information, Manufacturing Base and Competitors
Table 98. Juventas Major Business
Table 99. Juventas CD19 Target Drug Product and Services
Table 100. Juventas CD19 Target Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Juventas Recent Developments/Updates
Table 102. Juventas Competitive Strengths & Weaknesses
Table 103. FOSUN PHARMA Basic Information, Manufacturing Base and Competitors
Table 104. FOSUN PHARMA Major Business
Table 105. FOSUN PHARMA CD19 Target Drug Product and Services
Table 106. FOSUN PHARMA CD19 Target Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. FOSUN PHARMA Recent Developments/Updates
Table 108. JW Therapeutics Basic Information, Manufacturing Base and Competitors
Table 109. JW Therapeutics Major Business
Table 110. JW Therapeutics CD19 Target Drug Product and Services
Table 111. JW Therapeutics CD19 Target Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 112. Global Key Players of CD19 Target Drug Upstream (Raw Materials)
Table 113. CD19 Target Drug Typical Customers
Table 114. CD19 Target Drug Typical Distributors
LIST OF FIGURE
Figure 1. CD19 Target Drug Picture
Figure 2. World CD19 Target Drug Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World CD19 Target Drug Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World CD19 Target Drug Production (2018-2029) & (K Units)
Figure 5. World CD19 Target Drug Average Price (2018-2029) & (US$/Unit)
Figure 6. World CD19 Target Drug Production Value Market Share by Region (2018-2029)
Figure 7. World CD19 Target Drug Production Market Share by Region (2018-2029)
Figure 8. North America CD19 Target Drug Production (2018-2029) & (K Units)
Figure 9. Europe CD19 Target Drug Production (2018-2029) & (K Units)
Figure 10. China CD19 Target Drug Production (2018-2029) & (K Units)
Figure 11. Japan CD19 Target Drug Production (2018-2029) & (K Units)
Figure 12. CD19 Target Drug Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World CD19 Target Drug Consumption (2018-2029) & (K Units)
Figure 15. World CD19 Target Drug Consumption Market Share by Region (2018-2029)
Figure 16. United States CD19 Target Drug Consumption (2018-2029) & (K Units)
Figure 17. China CD19 Target Drug Consumption (2018-2029) & (K Units)
Figure 18. Europe CD19 Target Drug Consumption (2018-2029) & (K Units)
Figure 19. Japan CD19 Target Drug Consumption (2018-2029) & (K Units)
Figure 20. South Korea CD19 Target Drug Consumption (2018-2029) & (K Units)
Figure 21. ASEAN CD19 Target Drug Consumption (2018-2029) & (K Units)
Figure 22. India CD19 Target Drug Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of CD19 Target Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for CD19 Target Drug Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for CD19 Target Drug Markets in 2022
Figure 26. United States VS China: CD19 Target Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: CD19 Target Drug Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: CD19 Target Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers CD19 Target Drug Production Market Share 2022
Figure 30. China Based Manufacturers CD19 Target Drug Production Market Share 2022
Figure 31. Rest of World Based Manufacturers CD19 Target Drug Production Market Share 2022
Figure 32. World CD19 Target Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World CD19 Target Drug Production Value Market Share by Type in 2022
Figure 34. CD19 Target
Figure 35. CD19+CD3 Target
Figure 36. CD19+DNA Target
Figure 37. World CD19 Target Drug Production Market Share by Type (2018-2029)
Figure 38. World CD19 Target Drug Production Value Market Share by Type (2018-2029)
Figure 39. World CD19 Target Drug Average Price by Type (2018-2029) & (US$/Unit)
Figure 40. World CD19 Target Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World CD19 Target Drug Production Value Market Share by Application in 2022
Figure 42. Lymphoma
Figure 43. Acute Lymphoblastic Leukemia
Figure 44. Other
Figure 45. World CD19 Target Drug Production Market Share by Application (2018-2029)
Figure 46. World CD19 Target Drug Production Value Market Share by Application (2018-2029)
Figure 47. World CD19 Target Drug Average Price by Application (2018-2029) & (US$/Unit)
Figure 48. CD19 Target Drug Industry Chain
Figure 49. CD19 Target Drug Procurement Model
Figure 50. CD19 Target Drug Sales Model
Figure 51. CD19 Target Drug Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
Table 1. World CD19 Target Drug Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World CD19 Target Drug Production Value by Region (2018-2023) & (USD Million)
Table 3. World CD19 Target Drug Production Value by Region (2024-2029) & (USD Million)
Table 4. World CD19 Target Drug Production Value Market Share by Region (2018-2023)
Table 5. World CD19 Target Drug Production Value Market Share by Region (2024-2029)
Table 6. World CD19 Target Drug Production by Region (2018-2023) & (K Units)
Table 7. World CD19 Target Drug Production by Region (2024-2029) & (K Units)
Table 8. World CD19 Target Drug Production Market Share by Region (2018-2023)
Table 9. World CD19 Target Drug Production Market Share by Region (2024-2029)
Table 10. World CD19 Target Drug Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World CD19 Target Drug Average Price by Region (2024-2029) & (US$/Unit)
Table 12. CD19 Target Drug Major Market Trends
Table 13. World CD19 Target Drug Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World CD19 Target Drug Consumption by Region (2018-2023) & (K Units)
Table 15. World CD19 Target Drug Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World CD19 Target Drug Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key CD19 Target Drug Producers in 2022
Table 18. World CD19 Target Drug Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key CD19 Target Drug Producers in 2022
Table 20. World CD19 Target Drug Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global CD19 Target Drug Company Evaluation Quadrant
Table 22. World CD19 Target Drug Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and CD19 Target Drug Production Site of Key Manufacturer
Table 24. CD19 Target Drug Market: Company Product Type Footprint
Table 25. CD19 Target Drug Market: Company Product Application Footprint
Table 26. CD19 Target Drug Competitive Factors
Table 27. CD19 Target Drug New Entrant and Capacity Expansion Plans
Table 28. CD19 Target Drug Mergers & Acquisitions Activity
Table 29. United States VS China CD19 Target Drug Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China CD19 Target Drug Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China CD19 Target Drug Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based CD19 Target Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers CD19 Target Drug Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers CD19 Target Drug Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers CD19 Target Drug Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers CD19 Target Drug Production Market Share (2018-2023)
Table 37. China Based CD19 Target Drug Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers CD19 Target Drug Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers CD19 Target Drug Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers CD19 Target Drug Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers CD19 Target Drug Production Market Share (2018-2023)
Table 42. Rest of World Based CD19 Target Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers CD19 Target Drug Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers CD19 Target Drug Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers CD19 Target Drug Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers CD19 Target Drug Production Market Share (2018-2023)
Table 47. World CD19 Target Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World CD19 Target Drug Production by Type (2018-2023) & (K Units)
Table 49. World CD19 Target Drug Production by Type (2024-2029) & (K Units)
Table 50. World CD19 Target Drug Production Value by Type (2018-2023) & (USD Million)
Table 51. World CD19 Target Drug Production Value by Type (2024-2029) & (USD Million)
Table 52. World CD19 Target Drug Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World CD19 Target Drug Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World CD19 Target Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World CD19 Target Drug Production by Application (2018-2023) & (K Units)
Table 56. World CD19 Target Drug Production by Application (2024-2029) & (K Units)
Table 57. World CD19 Target Drug Production Value by Application (2018-2023) & (USD Million)
Table 58. World CD19 Target Drug Production Value by Application (2024-2029) & (USD Million)
Table 59. World CD19 Target Drug Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World CD19 Target Drug Average Price by Application (2024-2029) & (US$/Unit)
Table 61. ADC Therapeutics SA Basic Information, Manufacturing Base and Competitors
Table 62. ADC Therapeutics SA Major Business
Table 63. ADC Therapeutics SA CD19 Target Drug Product and Services
Table 64. ADC Therapeutics SA CD19 Target Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. ADC Therapeutics SA Recent Developments/Updates
Table 66. ADC Therapeutics SA Competitive Strengths & Weaknesses
Table 67. Bristol Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 68. Bristol Myers Squibb Major Business
Table 69. Bristol Myers Squibb CD19 Target Drug Product and Services
Table 70. Bristol Myers Squibb CD19 Target Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Bristol Myers Squibb Recent Developments/Updates
Table 72. Bristol Myers Squibb Competitive Strengths & Weaknesses
Table 73. Kite Pharma, Inc. Basic Information, Manufacturing Base and Competitors
Table 74. Kite Pharma, Inc. Major Business
Table 75. Kite Pharma, Inc. CD19 Target Drug Product and Services
Table 76. Kite Pharma, Inc. CD19 Target Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Kite Pharma, Inc. Recent Developments/Updates
Table 78. Kite Pharma, Inc. Competitive Strengths & Weaknesses
Table 79. Viela Bio Basic Information, Manufacturing Base and Competitors
Table 80. Viela Bio Major Business
Table 81. Viela Bio CD19 Target Drug Product and Services
Table 82. Viela Bio CD19 Target Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Viela Bio Recent Developments/Updates
Table 84. Viela Bio Competitive Strengths & Weaknesses
Table 85. Novartis Pharma AG Basic Information, Manufacturing Base and Competitors
Table 86. Novartis Pharma AG Major Business
Table 87. Novartis Pharma AG CD19 Target Drug Product and Services
Table 88. Novartis Pharma AG CD19 Target Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Novartis Pharma AG Recent Developments/Updates
Table 90. Novartis Pharma AG Competitive Strengths & Weaknesses
Table 91. Amgen, Inc. Basic Information, Manufacturing Base and Competitors
Table 92. Amgen, Inc. Major Business
Table 93. Amgen, Inc. CD19 Target Drug Product and Services
Table 94. Amgen, Inc. CD19 Target Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Amgen, Inc. Recent Developments/Updates
Table 96. Amgen, Inc. Competitive Strengths & Weaknesses
Table 97. Juventas Basic Information, Manufacturing Base and Competitors
Table 98. Juventas Major Business
Table 99. Juventas CD19 Target Drug Product and Services
Table 100. Juventas CD19 Target Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Juventas Recent Developments/Updates
Table 102. Juventas Competitive Strengths & Weaknesses
Table 103. FOSUN PHARMA Basic Information, Manufacturing Base and Competitors
Table 104. FOSUN PHARMA Major Business
Table 105. FOSUN PHARMA CD19 Target Drug Product and Services
Table 106. FOSUN PHARMA CD19 Target Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. FOSUN PHARMA Recent Developments/Updates
Table 108. JW Therapeutics Basic Information, Manufacturing Base and Competitors
Table 109. JW Therapeutics Major Business
Table 110. JW Therapeutics CD19 Target Drug Product and Services
Table 111. JW Therapeutics CD19 Target Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 112. Global Key Players of CD19 Target Drug Upstream (Raw Materials)
Table 113. CD19 Target Drug Typical Customers
Table 114. CD19 Target Drug Typical Distributors
LIST OF FIGURE
Figure 1. CD19 Target Drug Picture
Figure 2. World CD19 Target Drug Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World CD19 Target Drug Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World CD19 Target Drug Production (2018-2029) & (K Units)
Figure 5. World CD19 Target Drug Average Price (2018-2029) & (US$/Unit)
Figure 6. World CD19 Target Drug Production Value Market Share by Region (2018-2029)
Figure 7. World CD19 Target Drug Production Market Share by Region (2018-2029)
Figure 8. North America CD19 Target Drug Production (2018-2029) & (K Units)
Figure 9. Europe CD19 Target Drug Production (2018-2029) & (K Units)
Figure 10. China CD19 Target Drug Production (2018-2029) & (K Units)
Figure 11. Japan CD19 Target Drug Production (2018-2029) & (K Units)
Figure 12. CD19 Target Drug Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World CD19 Target Drug Consumption (2018-2029) & (K Units)
Figure 15. World CD19 Target Drug Consumption Market Share by Region (2018-2029)
Figure 16. United States CD19 Target Drug Consumption (2018-2029) & (K Units)
Figure 17. China CD19 Target Drug Consumption (2018-2029) & (K Units)
Figure 18. Europe CD19 Target Drug Consumption (2018-2029) & (K Units)
Figure 19. Japan CD19 Target Drug Consumption (2018-2029) & (K Units)
Figure 20. South Korea CD19 Target Drug Consumption (2018-2029) & (K Units)
Figure 21. ASEAN CD19 Target Drug Consumption (2018-2029) & (K Units)
Figure 22. India CD19 Target Drug Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of CD19 Target Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for CD19 Target Drug Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for CD19 Target Drug Markets in 2022
Figure 26. United States VS China: CD19 Target Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: CD19 Target Drug Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: CD19 Target Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers CD19 Target Drug Production Market Share 2022
Figure 30. China Based Manufacturers CD19 Target Drug Production Market Share 2022
Figure 31. Rest of World Based Manufacturers CD19 Target Drug Production Market Share 2022
Figure 32. World CD19 Target Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World CD19 Target Drug Production Value Market Share by Type in 2022
Figure 34. CD19 Target
Figure 35. CD19+CD3 Target
Figure 36. CD19+DNA Target
Figure 37. World CD19 Target Drug Production Market Share by Type (2018-2029)
Figure 38. World CD19 Target Drug Production Value Market Share by Type (2018-2029)
Figure 39. World CD19 Target Drug Average Price by Type (2018-2029) & (US$/Unit)
Figure 40. World CD19 Target Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World CD19 Target Drug Production Value Market Share by Application in 2022
Figure 42. Lymphoma
Figure 43. Acute Lymphoblastic Leukemia
Figure 44. Other
Figure 45. World CD19 Target Drug Production Market Share by Application (2018-2029)
Figure 46. World CD19 Target Drug Production Value Market Share by Application (2018-2029)
Figure 47. World CD19 Target Drug Average Price by Application (2018-2029) & (US$/Unit)
Figure 48. CD19 Target Drug Industry Chain
Figure 49. CD19 Target Drug Procurement Model
Figure 50. CD19 Target Drug Sales Model
Figure 51. CD19 Target Drug Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
